Effectiveness of palonosetron, 1-day dexamethasone, and aprepitant in patients undergoing carboplatin-based chemotherapy.

Toshinobu Hayashi,Mototsugu Shimokawa,Koichi Matsuo,Masanobu Uchiyama,Kei Kawada,Takafumi Nakano,Takashi Egawa

Oncology（2023）

引用 0|浏览10

暂无评分

摘要

Careful patient selection and symptom monitoring are needed when implementing the DEX-sparing strategy in triplet antiemetic prophylaxis for patients undergoing CBDCA-based chemotherapy. Furthermore, additional strategies may be needed to achieve better control of delayed CINV.

查看译文

关键词

antiemetics, chemotherapy-induced nausea and vomiting, steroid-sparing, dexamethasone, carboplatin, palonosetron

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要